Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Ocular Therapeutix, Inc. (OCUL) had Receiveable Turnover of 0.47 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$14.54M |
|
$-69.42M |
|
$1.77M |
|
$12.77M |
|
$83.24M |
|
$-68.70M |
|
$-0.72M |
|
$-69.42M |
|
$-69.42M |
|
$-69.42M |
|
$-69.42M |
|
$-69.42M |
|
$-69.42M |
|
$-68.70M |
|
$-67.63M |
|
183.92M |
|
183.92M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$386.98M |
|
$16.95M |
|
$23.90M |
|
$410.88M |
|
$49.29M |
|
$70.62M |
|
$103.36M |
|
$152.65M |
|
$258.23M |
|
$258.23M |
|
$258.23M |
|
174.95M |
|
| Cash Flow Statement Financials | |
$-150.63M |
|
$-9.04M |
|
$112.34M |
|
$393.72M |
|
$346.39M |
|
$-47.33M |
|
$31.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.85 |
|
-- |
|
-- |
|
0.21 |
|
0.27 |
|
87.80% |
|
-472.35% |
|
-472.35% |
|
-- |
|
-477.30% |
|
-477.30% |
|
$-159.68M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.51 |
|
|
Receiveable Turnover |
0.47 |
190.40 |
|
-26.88% |
|
-26.88% |
|
-16.89% |
|
-21.11% |
|
$1.48 |
|
$-0.87 |
|
$-0.82 |
|